Search Results 41-50 of 16809 for Bioavailability

  1. Licensed technology - Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

    The Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., at Mayo Clinic has developed a transformed sinusoidal endothelial cell ...

  2. Vitamin E - Mayo Clinic

    Pharmacology and pharmacokinetics of vitamin E: Nanoformulations to enhance bioavailability. International Journal of Nanomedicine. 2020; doi:10.2147/IJN ...

  3. Consumer health Medications - Mayo Clinic

    Meditation. Yoga. Massage. Acupuncture. Use of supplements, such as vitamins, herbs and minerals. Music therapy. Integrative medicine aims to fit each person's ...

  4. Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia - Mayo Clinic

    ... bioavailability of H3B-8800 (RVT-2001) or absorption of vitamins. Persistent clinically significant ≥ Grade 2 toxicities from previous chemotherapy ...

  5. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

    ... bioavailability of tazemetostat are not eligible. Patients with uncontrolled intercurrent illness including, but not limited to, ongoing or active infection ...

  6. Cutaneous B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

    CCS1477 is a potent, selective and orally bioavailable inhibitor of the bromodomain of p300 and CBP, critical transcriptional co-activators of genes that drive ...

  7. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    ... bioavailability of tazemetostat. 11. Significant cardiovascular impairment: history of congestive heart failure greater than New York Heart Association ...

  8. A Study to Assess in Vivo the Cellular Metabolism of Humans - Mayo Clinic

    About this study. The purpose of this study is to establish an arterial/venous method to measure the activity of the Tricarboxylic Acid or cell metabolism ...

  9. A Study of Everolimus with or without Bevacizumab for Treating Patients with Advanced Kidney Cancer that Progressed after First-Line Therapy - Mayo Clinic

    Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can interfere ...

  10. Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score - Mayo Clinic

    ... bioavailability of some HCV medications. HCV viral testing is not required for eligibility for this protocol. For patients entering the Intensification ...